Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 43, 2013 - Issue 7
Submit an article Journal homepage
399
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism

Shripad D. ChitnisDepartment of Biomedical and Pharmaceutical Sciences, University of Rhode Island Kingston, RIUSA
,
Ken OgasawaraDepartment of Biomedical and Pharmaceutical Sciences, University of Rhode Island Kingston, RIUSA
,
Björn SchniedewindiC42 Clinical Research & Development, Department of Anaesthesiology, University of Colorado Denver Aurora, COUSA
,
Reginald Y. GohhDivision of Organ Transplantation, Rhode Island Hospital, Warren Alpert Medical School of Brown University Providence, RIUSA
,
Uwe ChristiansiC42 Clinical Research & Development, Department of Anaesthesiology, University of Colorado Denver Aurora, COUSA
&
Fatemeh AkhlaghiDepartment of Biomedical and Pharmaceutical Sciences, University of Rhode Island Kingston, RIUSACorrespondence[email protected]
Pages 641-649 | Received 02 Oct 2012, Accepted 19 Nov 2012, Published online: 02 Jan 2013

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jianjun Ruan, Heyu Meng, Yanqiu Chen, Zhaohan Yan, Xiangdong Li & Fanbo Meng. (2022) Expression of ATP-binding cassette subfamily B member 1 gene in peripheral blood of patients with acute myocardial infarction. Bioengineered 13:4, pages 11095-11105.
Read now

Articles from other publishers (16)

Violetta Dziedziejko, Krzysztof Safranow, Mirosława Kijko-Nowak, Damian Malinowski, Leszek Domanski & Andrzej Pawlik. (2023) Leptin receptor gene polymorphisms in kidney transplant patients with post-transplant diabetes mellitus treated with tacrolimus. International Immunopharmacology 124, pages 110989.
Crossref
Violetta Dziedziejko, Krzysztof Safranow, Mirosława Kijko-Nowak, Jerzy Sieńko, Damian Malinowski, Kamila Szumilas & Andrzej Pawlik. (2023) The Association between CDKAL1 Gene rs10946398 Polymorphism and Post-Transplant Diabetes in Kidney Allograft Recipients Treated with Tacrolimus. Genes 14:8, pages 1595.
Crossref
Toshinori Hirai, Yoshihiko Morikawa, Ritsuki Onishi, Yusuke Nakatani, Kouhei Nishikawa, Takahiro Inoue & Takuya Iwamoto. (2023) Impact of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation. British Journal of Clinical Pharmacology 89:6, pages 1852-1861.
Crossref
Kannan Sridharan & Shamik Shah. (2023) Developing supervised machine learning algorithms to evaluate the therapeutic effect and laboratory-related adverse events of cyclosporine and tacrolimus in renal transplants. International Journal of Clinical Pharmacy 45:3, pages 659-668.
Crossref
Kelsey Coffman, Neha Patel, Felicia Bartlett, Jessica Newman, Shikha Patel, Taylor Sprague, Nikhil Rao, Erika Andrade, Michael J. Casey, Vinayak Rohan, Derek DuBay & David Taber. (2023) Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP‐tacrolimus conversion ratios. Clinical Transplantation 37:5.
Crossref
Norliza Mat Ariffin, Farida Islahudin, Endang Kumolosasi & Mohd Makmor-Bakry. (2019) Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers. Parasitology Research 118:3, pages 1011-1018.
Crossref
Kalluri Thishya, Kiran Kumar Vattam, Shaik Mohammad Naushad, Shree Bhushan Raju & Vijay Kumar Kutala. (2018) Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation. PLOS ONE 13:4, pages e0191921.
Crossref
Zahra Tolou-Ghamari. (2017) Pharmacotherapy of Prograf (Tacrolimus) in Liver Transplant Recipients; Consideration of Its' Levels with Efficacy and Toxicity. Jentashapir Journal of Health Research Inpress:Inpress.
Crossref
Jeannine S. McCune & Meagan J. Bemer. (2015) Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I. Clinical Pharmacokinetics 55:5, pages 525-550.
Crossref
Christoph Seger, Maria Shipkova, Uwe Christians, Elaine M. Billaud, Ping Wang, David W. Holt, Mercè Brunet, Paweł K. Kunicki, Thomasz Pawiński, Loralie J. Langman, Pierre Marquet, Michael Oellerich, Eberhard Wieland & Pierre Wallemacq. (2016) Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice. Therapeutic Drug Monitoring 38:2, pages 170-189.
Crossref
Joanna Giebułtowicz & Grzegorz Nałęcz-Jawecki. (2016) Occurrence of immunosuppressive drugs and their metabolites in the sewage-impacted Vistula and Utrata Rivers and in tap water from the Warsaw region (Poland). Chemosphere 148, pages 137-147.
Crossref
Maciej Romanowski, Violetta Dziedziejko, Agnieszka Maciejewska-Karlowska, Marek Sawczuk, Krzysztof Safranow, Leszek Domanski & Andrzej Pawlik. (2015) Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus. Pharmacogenomics 16:11, pages 1243-1252.
Crossref
Wei-Long Shi, Hui-Lin Tang & Suo-Di Zhai. (2015) Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis. PLOS ONE 10:6, pages e0127995.
Crossref
Sourabh Chand, Amy Jayne McKnight & Richard Borrows. (2014) Genetic polymorphisms and kidney transplant outcomes. Current Opinion in Nephrology and Hypertension 23:6, pages 605-610.
Crossref
Ileana A. Ionita, Ken Ogasawara, Reginald Y. Gohh & Fatemeh Akhlaghi. (2014) Pharmacokinetics of Total and Unbound Prednisone and Prednisolone in Stable Kidney Transplant Recipients With Diabetes Mellitus. Therapeutic Drug Monitoring 36:4, pages 448-455.
Crossref
Ken Ogasawara, Shripad D. Chitnis, Reginald Y. Gohh, Uwe Christians & Fatemeh Akhlaghi. (2013) Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients. Clinical Pharmacokinetics 52:9, pages 751-762.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.